Abstract
Background: Recently, increasing antibiotic resistance is causing serious publichealth concerns worldwide. This phenomenon increased patient's morbidity and mortality rate, particularly in immunocompromised individuals.
Methods: Considering that antimicrobial resistance can vary according to geographical location, we investigated the status of antibiotic resistance in Ilam province from 2008 to 2013.
Results: The results of our study showed that antibiotic resistance rates to aztreonam, cefotaxime, ceftazidime and ceftriaxone were 38%, 39%, 43% and 48% respectively.
Conclusion: Antibiotic resistance had increased (except for aztreonam) during the period from 2008 to 2013.
Keywords: Antibiotic resistances, antimicrobial resistance, meta-analysis, monobactam, Ilam, ceftazidime.
Recent Patents on Anti-Infective Drug Discovery
Title:3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis
Volume: 12 Issue: 1
Author(s): Saeed Hemati, Sobhan Ghafourian, Nourkhoda Sadeghfard, Zahra Mahdavi, Abbas Maleki, Fatemeh Sayehmiri, Kouroush Sayehmiri, Lidija Bogdanovic and Morovat Taherikalani*
Affiliation:
- Razi Herbal Medicines Research Center & Department of Microbiology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad,Iran
Keywords: Antibiotic resistances, antimicrobial resistance, meta-analysis, monobactam, Ilam, ceftazidime.
Abstract: Background: Recently, increasing antibiotic resistance is causing serious publichealth concerns worldwide. This phenomenon increased patient's morbidity and mortality rate, particularly in immunocompromised individuals.
Methods: Considering that antimicrobial resistance can vary according to geographical location, we investigated the status of antibiotic resistance in Ilam province from 2008 to 2013.
Results: The results of our study showed that antibiotic resistance rates to aztreonam, cefotaxime, ceftazidime and ceftriaxone were 38%, 39%, 43% and 48% respectively.
Conclusion: Antibiotic resistance had increased (except for aztreonam) during the period from 2008 to 2013.
Export Options
About this article
Cite this article as:
Hemati Saeed, Ghafourian Sobhan, Sadeghfard Nourkhoda, Mahdavi Zahra, Maleki Abbas, Sayehmiri Fatemeh, Sayehmiri Kouroush, Bogdanovic Lidija and Taherikalani Morovat*, 3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis, Recent Patents on Anti-Infective Drug Discovery 2017; 12 (1) . https://dx.doi.org/10.2174/1574891X12666170130101006
DOI https://dx.doi.org/10.2174/1574891X12666170130101006 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Invasive Aspergillosis in Children and Adolescents
Current Pharmaceutical Design Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews Molecular Binding and Simulation Studies of Staphylococcus aureus Superantigens with Flavonoid Compounds
Infectious Disorders - Drug Targets Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications
Current Radiopharmaceuticals Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
Current Psychopharmacology Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI
Current Pharmaceutical Biotechnology The First Years of Linezolid Experience in Clinical Practice: A Balance and Future Implications
Anti-Infective Agents in Medicinal Chemistry Production and Application of Bacteriophage and Bacteriophage-Encoded Lysins
Recent Patents on Biotechnology High Sensitivity C-Reactive Protein (hsCRP): A New Biochemical Marker of Atherosclerotic Vascular Disease
Current Cardiology Reviews Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
Current Protein & Peptide Science HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Pharmacogenomics and Severe Infections: The Role of the Genomes of Both the Host and the Pathogen
Current Pharmacogenomics Ethanol and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design Elucidating Protein-protein Interactions Through Computational Approaches and Designing Small Molecule Inhibitors Against them for Various Diseases
Current Topics in Medicinal Chemistry Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Current Pharmaceutical Design Vasopressin and Terlipressin in Neonates and Children with Refractory Septic Shock
Current Drug Metabolism Biosynthesis and Genetic Engineering of Lipopeptide Antibiotics Related to Daptomycin
Current Topics in Medicinal Chemistry Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
Current Pharmaceutical Design